[1]
|
Pichler, W.J. (2003) Delayed drug hypersensitivity reactions. Annals of Internal Medicine, 139, 683-693.
http://dx.doi.org/10.7326/0003-4819-139-8-200310210-00012
|
[2]
|
Castrejon, J.L., et al. (2010) Stimulation of human T cells with sulfonamides and sulfonamide metabolites. Journal of Allergy and Clinical Immunology, 125, 411-418.
|
[3]
|
Mauri-Hellweg, D., et al. (1995) Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. Journal of Immunology, 155, 462-472.
|
[4]
|
von Greyerz, S., et al. (1999) Interaction of sulfonamide derivatives with the TCR of sulfamethoxazole-specific human alpha beta+ T cell clones. Journal of Immunology, 162, 595-602.
|
[5]
|
Schnyder, B., et al. (1997) Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones. Journal of Clinical Investigation, 100, 136-141. http://dx.doi.org/10.1172/JCI119505
|
[6]
|
Pichler, W.J. (2002) Pharmacological interaction of drugs with antigen-specific immune receptors: The p-i concept. Current Opinion in Allergy and Clinical Immunology, 2, 301-305.
http://dx.doi.org/10.1097/00130832-200208000-00003
|
[7]
|
Pichler, W.J., et al. (2006) Pharmacological interaction of drugs with immune receptors: The p-i concept. Allergology International, 55, 17-25.
http://dx.doi.org/10.2332/allergolint.55.17
|
[8]
|
Alarcon, B., Mestre, D. and Martinez-Martin, N. (2011) The immunological synapse: A cause or consequence of T-cell receptor triggering? Immunology, 133, 420-425.
http://dx.doi.org/10.1111/j.1365-2567.2011.03458.x
|
[9]
|
Kummerow, C., et al. (2009) The immunological synapse controls local and global calcium signals in T lymphocytes. Immunological Reviews, 231, 132-147.
http://dx.doi.org/10.1111/j.1600-065X.2009.00811.x
|
[10]
|
Oltz, E.M. (2001) Regulation of antigen receptor gene assembly in lymphocytes. Immunologic Research, 23, 121- 133. http://dx.doi.org/10.1385/IR:23:2-3:121
|
[11]
|
de Bakker, P.I., et al. (2006) A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nature Genetics, 38, 1166-1172.
http://dx.doi.org/10.1038/ng1885
|
[12]
|
Adam, J., Pichler, W.J. and Yerly, D. (2011) Delayed drug hypersensitivity: Models of T-cell stimulation. British Journal of Clinical Pharmacology, 71, 701-707.
http://dx.doi.org/10.1111/j.1365-2125.2010.03764.x
|
[13]
|
Adam, J., et al. (2012) Avidity determines T-cell reactivity in abacavir hypersensitivity. European Journal of Immunology, 42, 1706-1716.
http://dx.doi.org/10.1002/eji.201142159
|
[14]
|
Pavlos, R., Mallal, S. and Phillips, E. (2012) HLA and pharmacogenetics of drug hypersensitivity. Pharmacogenomics, 13, 1285-1306.
http://dx.doi.org/10.2217/pgs.12.108
|
[15]
|
Wei, C.Y., et al. (2012) Direct interaction between HLAB and carbamazepine activates T cells in patients with Stevens-Johnson syndrome. Journal of Allergy and Clinical Immunology, 129, 1562-1569.
|
[16]
|
Yang, C.W., et al. (2007) HLA-B*1502-bound peptides: implications for the pathogenesis of carbamazepine-induced Stevens-Johnson syndrome. Journal of Allergy and Clinical Immunology, 120, 870-877.
http://dx.doi.org/10.1016/j.jaci.2007.06.017
|
[17]
|
Illing, P.T., et al. (2012) Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature, 486, 554-558.
|
[18]
|
Ostrov, D.A., et al. (2012) Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proceedings of the National Academy of Sciences of USA, 109, 9959-9964.
http://dx.doi.org/10.1073/pnas.1207934109
|
[19]
|
Norcross, M.A., et al. (2012) Abacavir induces loading of novel self-peptides into HLA-B*57: 01: An autoimmune model for HLA-associated drug hypersensitivity. AIDS, 26, F21-F29.
http://dx.doi.org/10.1097/QAD.0b013e328355fe8f
|
[20]
|
Dickhaut, K., et al. (2009) Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE). PLoS One, 4, e6811.
http://dx.doi.org/10.1371/journal.pone.0006811
|
[21]
|
von Greyerz, S., et al. (2001) Degeneracy and additional alloreactivity of drug-specific human alpha beta(+) T cell clones. International Immunology, 13, 877-885.
http://dx.doi.org/10.1093/intimm/13.7.877
|
[22]
|
Zanni, M.P., et al. (1998) Allele-unrestricted presentation of lidocaine by HLA-DR molecules to specific alphabeta+ T cell clones. International Immunology, 10, 507- 515. http://dx.doi.org/10.1093/intimm/10.4.507
|
[23]
|
Schmid, D.A., et al. (2006) Transfection of drug-specific T-cell receptors into hybridoma cells: tools to monitor drug interaction with T-cell receptors and evaluate cross- reactivity to related compounds. Molecular Pharmacology, 70, 356-365.
|
[24]
|
Burkhart, C., et al. (2002) Non-covalent presentation of sulfamethoxazole to human CD4+ T cells is independent of distinct human leucocyte antigen-bound peptides. Clinical & Experimental Allergy, 32, 1635-1643.
http://dx.doi.org/10.1046/j.1365-2222.2002.01513.x
|
[25]
|
Zanni, M.P., et al. (1998) HLA-restricted, processing-and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes. Journal of Clinical Investigation, 102, 1591-1598.
http://dx.doi.org/10.1172/JCI3544
|
[26]
|
Yin, Y., Wang, X.X. and Mariuzza, R.A. (2012) Crystal structure of a complete ternary complex of T-cell receptor, peptide-MHC, and CD4. Proceedings of the National Academy of Sciences of USA, 109, 5405-5410.
http://dx.doi.org/10.1073/pnas.1118801109
|
[27]
|
Arechaga, I., et al. (2010) Structural characterization of the TCR complex by electron microscopy. International Immunology, 22, 897-903.
http://dx.doi.org/10.1093/intimm/dxq443
|
[28]
|
Vega-Hissi, E.G., et al. (2011) Theoretical studies on sulfanilamide and derivatives with antibacterial activity: conformational and electronic analysis. Journal of Molecular Modeling, 17, 1317-1323.
http://dx.doi.org/10.1007/s00894-010-0829-y
|
[29]
|
Halim M.A., D.M. Shaw and Poirier R.A. (2010) Medium effect on the equilibrium geometries, vibrational frequencies and solvation energies of sulfanilamide. Journal of Molecular Structure: THEOCHEM, 960, 63-72.
http://dx.doi.org/10.1016/j.theochem.2010.08.027
|
[30]
|
Depta, J.P., et al. (2004) Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross- reactivity. Journal of Allergy and Clinical Immunology, 113, 519-527. http://dx.doi.org/10.1016/j.jaci.2003.11.030
|
[31]
|
Burrows, S.R., et al. (2010) Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability. Proceedings of the National Academy of Sciences of USA, 107, 10608-10613.
http://dx.doi.org/10.1073/pnas.1004926107
|
[32]
|
Newell, E.W., et al. (2011) Structural basis of specificity and cross-reactivity in T cell receptors specific for cytochrome c-I-E(k). Journal of Immunology, 186, 5823-5832.
http://dx.doi.org/10.4049/jimmunol.1100197
|
[33]
|
Thomson, C.T., et al. (2001) A structural difference limited to one residue of the antigenic peptide can profoundly alter the biological outcome of the TCR-peptide/MHC class I interaction. Journal of Immunology, 166, 3994- 3997.
|
[34]
|
Reantragoon, R., et al. (2012) Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor. Journal of Experimental Medicine, 209, 761-774. http://dx.doi.org/10.1084/jem.20112095
|
[35]
|
Baker, B.M., et al. (2012) Structural and dynamic control of T-cell receptor specificity, cross-reactivity, and binding mechanism. Immunological Reviews, 250, 10-31.
http://dx.doi.org/10.1111/j.1600-065X.2012.01165.x
|
[36]
|
Ko, T.M., et al. (2011) Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens- Johnson syndrome. The Journal of Allergy and Clinical Immunology, 128, 1266-1276. e11.
|
[37]
|
Naisbitt, D.J., et al. (2001) Antigenicity and immunogenicity of sulphamethoxazole: Demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo. British Journal of Pharmacology, 133, 295-305.
doi:10.1038/sj.bjp.0704074
|
[38]
|
Theorell, J., et al. (2011) Sensitive and viable quantification of inside-out signals for LFA-1 activation in human cytotoxic lymphocytes by flow cytometry. Journal of Immunological Methods, 366, 106-118.
doi:10.1016/j.jim.2011.01.014
|
[39]
|
Arnold, K., et al. (2006) The SWISS-MODEL workspace: A web-based environment for protein structure homology modelling. Bioinformatics, 22, 195-201.
doi:10.1093/bioinformatics/bti770
|
[40]
|
Kleywegt, G.J. and Jones, T.A. (1996) Efficient rebuilding of protein structures. Acta Crystallographica Section D Biological Crystallography, 52, 829-832.
doi:10.1107/S0907444996001783
|
[41]
|
Van Der Spoel, D., et al. (2005) GROMACS: Fast, flexible, and free. Journal of Computational Chemistry, 26, 1701-1718. doi:10.1002/jcc.20291
|
[42]
|
Morris, G.M., Huey, R. and Olson, A.J. (2008) Using AutoDock for ligand-receptor docking. Current Protocols in Bioinformatics, 8, p. Unit 8. 14.
|
[43]
|
Trott, O. and Olson, A.J. (2010) AutoDock vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31, 455-461.
|
[44]
|
Plewczynski, D., et al. (2011) VoteDock: Consensus docking method for prediction of protein-ligand interactions. Journal of Computational Chemistry, 32, 568-581.
doi:10.1002/jcc.21642
|
[45]
|
Seeliger, D. and de Groot, B.L. (2010) Ligand docking and binding site analysis with PyMOL and Autodock/vina. Journal of Computer-Aided Molecular Design, 24, 417-422. doi:10.1007/s10822-010-9352-6
|